312 related articles for article (PubMed ID: 34775078)
1. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
[TBL] [Abstract][Full Text] [Related]
2. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour M; Eslami M; Nezafat N; Hajighahramani N; Ghoshoon MB; Shoolian E; Dehshahri A; Erfani N; Morowvat MH; Ghasemi Y
Infect Genet Evol; 2017 Oct; 54():402-416. PubMed ID: 28780192
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for sexually transmitted infections.
Rupp RE; Stanberry LR; Rosenthal SL
Pediatr Ann; 2005 Oct; 34(10):818-20, 822-4. PubMed ID: 16285635
[TBL] [Abstract][Full Text] [Related]
4. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine.
Negahdaripour M; Nezafat N; Eslami M; Ghoshoon MB; Shoolian E; Najafipour S; Morowvat MH; Dehshahri A; Erfani N; Ghasemi Y
Infect Genet Evol; 2018 Mar; 58():96-109. PubMed ID: 29253673
[TBL] [Abstract][Full Text] [Related]
5. Design of a novel multi-epitope vaccine candidate against
Abdulabbas HT; Mohammad Ali AN; Farjadfar A; Arabfard M; Najafipour S; Kouhpayeh A; Ghasemian A; Behmard E
J Biomol Struct Dyn; 2024 May; 42(8):4356-4369. PubMed ID: 37288800
[No Abstract] [Full Text] [Related]
6. Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.
Alberts CJ; Schim van der Loeff MF; Papenfuss MR; da Silva RJ; Villa LL; Lazcano-Ponce E; Nyitray AG; Giuliano AR
Sex Transm Dis; 2013 Jun; 40(6):508-15. PubMed ID: 23680908
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.
Wang X; Xie G; Liao J; Yin D; Guan W; Pan M; Li J; Li Y
Virol J; 2011 May; 8():232. PubMed ID: 21575169
[TBL] [Abstract][Full Text] [Related]
8. Future prospects for new vaccines against sexually transmitted infections.
Gottlieb SL; Johnston C
Curr Opin Infect Dis; 2017 Feb; 30(1):77-86. PubMed ID: 27922851
[TBL] [Abstract][Full Text] [Related]
9. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
[TBL] [Abstract][Full Text] [Related]
10. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.
Frietze KM; Lijek R; Chackerian B
Expert Rev Vaccines; 2018 Nov; 17(11):959-966. PubMed ID: 30300019
[TBL] [Abstract][Full Text] [Related]
11. Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: Implications for epitheliotropic sexually transmitted infections?
Silva J; Cerqueira F; Medeiros R
Life Sci; 2015 Oct; 139():62-8. PubMed ID: 26281916
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis and herpes simplex virus 2 infection in vulvar intraepithelial neoplasia associated with human papillomavirus.
Kwaśniewska A; Korobowicz E; Visconti J; Zdunek M; Szymańiski M; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2006; 27(4):405-8. PubMed ID: 17009637
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.
Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L
Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565
[TBL] [Abstract][Full Text] [Related]
15. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
Garnett GP
J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
Görander S; Lagergård T; Romanik M; Viscidi RP; Martirosian G; Liljeqvist JA
Clin Vaccine Immunol; 2008 Apr; 15(4):675-80. PubMed ID: 18287578
[TBL] [Abstract][Full Text] [Related]
17. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
Menezes LJ; Pokharel U; Sudenga SL; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; Engelbrecht S; Schim van der Loeff MF; van der Laan LE; Kipping S; Taylor D; Giuliano AR
Sex Transm Infect; 2018 Feb; 94(1):55-61. PubMed ID: 28490581
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Variable Domain 4 Linear Epitopes of the
Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
[No Abstract] [Full Text] [Related]
19. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L
Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528
[TBL] [Abstract][Full Text] [Related]
20. Vaccine candidates in STD.
Fletcher MA
Int J STD AIDS; 2001 Jul; 12(7):419-22. PubMed ID: 11394975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
